Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Neoplasms 4Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Prostatic Neoplasms 2Delirium 2Thrombocytopenia 1Stomatitis 1Pleural Effusion 1Pelvic Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic Neoplasms 1Pancreatic Cyst 1Ovarian Neoplasms 1Otolaryngeal Cancer 1Metabolic Diseases 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Kidney Neoplasms 1Hemostatic Disorders 1Head and Neck Neoplasms 1Emergence Delirium 1Chemotherapy-Related Cognitive Impairment 1Anemia, Aplastic 1

Interventions

Saline Solution 1Neuroprotective Agents 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Chemotherapy-Related Cognitive Impairment × Saline Solution × Clear all
NCT05239663 2024-08-01

GM1 Prophylaxis for Post-chemotherapy Cognitive Impairment in Patients With Early Operable Breast Cancer

Sun Yat-sen University

Phase 3 Terminated
76 enrolled
Breast

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡